Physician profile
Yingbo Yang
NPI 1720135510
$23,659.79
in general payments reported to CMS, 2019-2025
13 companies · $5,007 in 2025
The $5,007 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,299 · 2020: $137 · 2021: $1,484 · 2022: $1,778 · 2023: $6,256 · 2024: $6,700 · 2025: $5,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $6,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,848.36 |
| Food and Beverage | $6,113.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,619.17 | 2021-2024 | Ensite, Aveir, Ensite Precision |
| Medtronic, INC. | $5,808.42 | 2022-2025 | Pulseselect, Affera Mapping System, Cardioblate Cryoflex |
| Atricure, INC. | $2,450.45 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $2,243.77 | 2023-2025 | Farapulse, Rhythmia Mapping System, Emblem Mri S-Icd |
| Medtronic Vascular, INC. | $1,815.05 | 2019 | |
| Medical Device Business Services, INC. | $1,652.08 | 2021-2023 | Carto 3 |
| Biotronik INC. | $1,143.89 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Biosense Webster, INC. | $651.85 | 2021-2025 | Qdot Micro Catheter, Carto 3, Octaray Mapping Catheter |
| Impulse Dynamics (USA) INC. | $136.94 | 2020 | |
| Abiomed | $80.00 | 2022 | |
| Intuitive Surgical, INC. | $27.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yingbo Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.